Hospira Inc News Headlines

HSP 
$63.43
*  
1.35
2.08%
Get HSP Alerts
*Delayed - data as of Jan. 30, 2015  -  Find a broker to begin trading HSP now
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
1/21/2015 6:08:00 PM - Zacks.com


Why Johnson & Johnson's Stock Could Crater in 2015
1/21/2015 12:04:02 PM - Motley Fool


Hospira's Plum 36O Infusion System Gets FDA Clearance - Analyst Blog
1/21/2015 6:08:00 AM - Investopedia


Hospira Submits Retacrit Regulatory Application to the FDA - Analyst Blog
1/16/2015 11:10:00 AM - Investopedia


Hospira Submits Retacrit Regulatory Application to the FDA - Analyst Blog
1/16/2015 11:10:00 AM - Zacks.com


Hospira Inc. (HSP): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report
1/15/2015 7:00:00 AM - Investopedia


Hospira To Present At J.P. Morgan Healthcare Conference ; Webcast At 1:30 PM ET
1/14/2015 12:30:00 PM - RTT News


Hospira Submits New Biologics License Application Biosimilar Retacrit
1/12/2015 9:13:00 AM - RTT News


Hospira's Dyloject Cleared in the U.S. for Pain Management - Analyst Blog
12/31/2014 3:45:00 PM - Zacks.com


Epirus Biopharma: A High Risk/High Reward Biosimilar Investment
12/31/2014 6:59:00 AM - Seeking Alpha


Hospira's Dyloject Cleared in the U.S. for Pain Management - Analyst Blog
12/31/2014 3:45:00 AM - Investopedia


Hospira Obtains FDA Approval Of Proprietary Analgesic Dyloject Injection
12/30/2014 9:11:00 AM - RTT News


Is Boston Scientific (BSX) Worth Adding to Your Portfolio? - Analyst Blog
12/16/2014 4:50:00 PM - Zacks.com


2015 Healthcare Sector Predictions
12/16/2014 6:50:00 AM - Seeking Alpha


Danone To Retain Medical Nutrition Unit, Announces Management Changes
12/12/2014 7:43:00 AM - RTT News


Update: Cubist Pharmaceuticals Is Acquired By Merck, Gains Remain For Investors
12/11/2014 12:31:00 AM - Seeking Alpha


Merck-Cubist Deal On Despite Patent Setback, Shares Fall - Analyst Blog
12/10/2014 4:30:00 PM - Zacks.com


Cubist Shoots Up on $9.5 Billion Buyout Offer from Merck - Analyst Blog
12/9/2014 4:30:00 PM - Zacks.com


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling -- Update
12/9/2014 2:06:00 PM - Dow Jones Business News


Merck Committed To Cubist Pharma Acquisition Despite Patent Ruling
12/9/2014 9:53:00 AM - RTT News


Merck Reaffirms Commitment to Cubist Deal Despite Patent Ruling
12/9/2014 9:35:00 AM - Dow Jones Business News


Health Care Sector Update for 12/09/2014: ARIA, CBST, CELG
12/9/2014 8:50:21 AM - MT Newswires


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 6th Update
12/8/2014 10:01:00 PM - Dow Jones Business News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 5th Update
12/8/2014 6:16:00 PM - Dow Jones Business News


Merck to Buy Cubist Pharmaceuticals for $8.4 Billion -- 4th Update
12/8/2014 6:06:00 PM - Dow Jones Business News